Clover: trimerizing fusion proteins

Clover is developing trimerized fusion proteins to target cancer and infectious disease pathways that depend on trimer formation.

The company has exclusive, worldwide rights to its Trimer-Tag platform from GenHunter Corp., which was co-founded by Sichuan Clover Biopharmaceuticals Inc. co-founder, President and Chairman Peng Liang...